Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT04726358
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed NSCLC only
* Locally advanced disease (Stage III) with positive mediastinal nodes
* PET/CT staged
* Curative intent radiotherapy
* Chemotherapy (ChT): Without, Sequential ChT - Radiotherapy (RT) (max 2 cycles), Concurrent (± induction ChT)
* Prescription dose ≥ 60 Gy (EQD2)
Exclusion Criteria:
* Prior history of thoracic RT
* Malignant pleural effusion
* History of malignancy in the last 3 years, except basal-cell skin cancer and intra-epithelial neoplasia
* Progression after induction chemotherapy
* Use of concurrent targeted, immunomodulating or anti-angiogenic agents except if the patient is included in a clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04726358
Study Brief:
Protocol Section:
NCT04726358